A significant breakthrough in cancer investigation is emerging with the use of mini-antibodies to re-engage damaged p53. This vital cancer protector protein is frequently lost in many types of tumors, leading https://bookmark-dofollow.com/story29832123/nanobodies-reactivate-tumor-suppressor-p53-new-new-pathway-for-malignant-treatment